A detailed history of R.M.Sincerbeaux Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, R.M.Sincerbeaux Capital Management LLC holds 11,800 shares of ABT stock, worth $1.36 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
11,800
Previous 12,500 5.6%
Holding current value
$1.36 Million
Previous $1.42 Million 13.66%
% of portfolio
0.81%
Previous 0.91%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $70,511 - $78,708
-700 Reduced 5.6%
11,800 $1.23 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $34,608 - $38,223
-316 Reduced 2.47%
12,500 $1.42 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $61,689 - $75,513
-684 Reduced 5.07%
12,816 $1.41 Million
Q1 2023

May 08, 2023

SELL
$96.86 - $114.01 $24,215 - $28,502
-250 Reduced 1.82%
13,500 $1.37 Million
Q2 2022

Aug 02, 2022

SELL
$102.07 - $123.37 $20,414 - $24,674
-200 Reduced 1.43%
13,750 $1.49 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $46,664 - $51,624
-400 Reduced 2.79%
13,950 $1.65 Million
Q2 2020

Aug 12, 2020

SELL
$76.57 - $98.0 $957,124 - $1.23 Million
-12,500 Reduced 46.55%
14,350 $1.31 Million
Q4 2019

Feb 06, 2020

SELL
$78.51 - $87.4 $23,553 - $26,220
-300 Reduced 1.1%
26,850 $2.33 Million
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $24,552 - $26,622
300 Added 1.12%
27,150 $2.27 Million
Q2 2019

Aug 09, 2019

SELL
$72.88 - $85.0 $21,864 - $25,500
-300 Reduced 1.1%
26,850 $0
Q2 2018

Jul 31, 2018

BUY
$57.57 - $63.54 $17,271 - $19,062
300 Added 1.12%
27,150 $1.66 Million
Q3 2017

Nov 14, 2017

SELL
$48.06 - $53.64 $100,926 - $112,644
-2,100 Reduced 7.25%
26,850 $1.43 Million
Q2 2017

Aug 10, 2017

BUY
N/A
28,950
28,950 $1.41 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track R.M.Sincerbeaux Capital Management LLC Portfolio

Follow R.M.Sincerbeaux Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of R.M.Sincerbeaux Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on R.M.Sincerbeaux Capital Management LLC with notifications on news.